India has rapidly emerged as one of the world’s most advanced destinations for cancer care.
With world-class oncologists, cutting-edge technology, and treatment costs that are a fraction
of what you’d pay in the West, millions of patients — both Indian and international — are now
choosing India for their cancer treatment journey. In this blog, we walk you through the Top 10
advanced cancer treatments available in India in 2026, explaining how each works, its
benefits, and what success rates patients can realistically expect.
Did You Know?
India treats over 14 lakh new cancer patients every year. Top hospitals like AIIMS, Tata
Memorial, Apollo, and Fortis now offer the same advanced treatments found in the US or
UK — at 60–80% lower cost.
Immunotherapy (Checkpoint Inhibitors)
How It Works:
Immunotherapy trains your own immune system to recognize and destroy cancer cells. Drugs
called checkpoint inhibitors — like Pembrolizumab (Keytruda) and Nivolumab — block proteins
that cancer uses to ‘hide’ from immune cells.
Key Benefits:
● Works even after chemotherapy has failed
● Long-lasting remission in many patients
● Available for lung, skin (melanoma), bladder, and kidney cancers
● Less toxic than traditional chemo for many patients
Success Rate
30–45% objective response rate in advanced cancers; up to 20% achieve complete
remission in melanoma
| Approx. Cost in India Rs. 1.5–4 lakh per cycle (vs $15,000+ in the US) |
CAR-T Cell Therapy
How It Works:
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a revolutionary one-time treatment where
a patient’s own T-cells are collected, genetically engineered in a lab to attack cancer, and then
reinfused into the body. India’s first indigenously developed CAR-T therapy — NexCAR19 —
was approved in 2024.
Key Benefits:
● One-time treatment with potential lifelong benefit
● Highly effective in blood cancers (leukemia, lymphoma)
● India’s NexCAR19 costs just Rs. 40 lakh vs Rs. 4 crore+ abroad
● Now available at IIT Bombay–Actrec and select centres
Success Rate
70–90% complete remission in relapsed B-cell lymphoma cases
| Approx. Cost in India Rs. 30–50 lakh (India-made); Rs. 3–4 crore (imported) |
Proton Therapy
How It Works:
Proton therapy uses protons (instead of X-rays) to precisely target tumours. Unlike
conventional radiation, protons deposit most of their energy directly at the tumour and stop —
sparing surrounding healthy tissue. Available at Apollo Proton Cancer Centre (Chennai) and
Manipal (Bengaluru) in India.
Key Benefits:
● Ideal for brain, spine, head & neck, and paediatric cancers
● Significantly reduces radiation to heart and lungs
● Lower risk of secondary cancers — especially important for children
● Fewer side effects than conventional radiotherapy
Success Rate
90%+ local tumour control in prostate and skull-base cancers
| Approx. Cost in India Rs. 15–35 lakh (vs Rs. 1–2 crore in the US) |
Targeted Therapy
How It Works:
Targeted therapy uses drugs or antibodies that specifically target genetic mutations or proteins
that help cancer cells grow. Examples include Imatinib (for CML), Gefitinib/Erlotinib (for
EGFR+ lung cancer), and Trastuzumab (for HER2+ breast cancer). Treatment is personalised
based on genomic testing.
Key Benefits:
● Works only on cancer cells — minimal damage to healthy cells
● Oral tablets available for many types (easy to take at home)
● Dramatically improves survival in EGFR+ lung, HER2+ breast cancers
● Available across tier-1 and tier-2 cities in India
Success Rate
60–80% response rate in matched mutations (e.g., EGFR+ lung cancer PFS: 18–24
months)
| Approx. Cost in India Rs. 20,000–2.5 lakh/month depending on drug |
Robotic Surgery (da Vinci & Versius)
How It Works:
Robotic surgery allows surgeons to perform complex, minimally invasive cancer operations
with robotic arms offering far greater precision, range of motion, and 3D vision than the human
hand. Used for prostate, colorectal, gynecologic, and thoracic cancers. Over 80 robotic
systems now operational across India.
Key Benefits:
● Smaller incisions — less pain and faster recovery
● Less blood loss and lower infection risk
● Surgeons can access hard-to-reach tumours more safely
● Shorter hospital stay (2–3 days vs 7–10 days for open surgery)
Success Rate
Cancer clearance rates comparable to or better than open surgery; 95%+ margin-negative
resection in prostate cancer
Approx. Cost in India Rs. 3–8 lakh (vs Rs. 25–50 lakh in the US) |
Stereotactic Radiosurgery (CyberKnife / Gamma Knife)
How It Works:
Stereotactic radiosurgery delivers extremely precise, high-dose radiation beams to a tumour
from hundreds of angles — destroying it while sparing surrounding tissue. Despite the name
‘surgery’, no incisions are made. CyberKnife and Gamma Knife systems are available across
major Indian hospitals.
Key Benefits:
● Non-invasive — no cuts, no anaesthesia required
● Treats brain tumours, spinal tumours, and lung nodules
● Typically completed in 1–5 sessions
● Can treat patients who are not surgical candidates
Success Rate
85–95% local tumour control for brain metastases and acoustic neuromas
| Approx. Cost in India Rs. 2.5–6 lakh per course |
HIPEC (Hyperthermic Intraperitoneal Chemotherapy)
How It Works:
HIPEC is a specialised surgical procedure where heated chemotherapy drugs (42–43°C) are
washed directly inside the abdominal cavity immediately after surgical removal of visible
tumours. The heat enhances the chemo’s cancer-killing ability. Used for peritoneal cancers
(appendix, colon, ovarian).
Key Benefits:
● Direct delivery of chemo to abdominal cancer — 5x more effective
● Removes microscopic cancer cells missed by surgery alone
● Offers potential cure for select peritoneal cancers
● Available at Tata Memorial, Apollo, and Manipal
Success Rate
Median survival improves from 12 months to 50+ months in colorectal peritoneal cancer
| Approx. Cost in India Rs. 5–10 lakh |
Bone Marrow / Stem Cell Transplant
How It Works:
Stem cell transplantation replaces diseased bone marrow with healthy stem cells — either from
the patient (autologous) or a donor (allogeneic). It is used after high-dose chemotherapy to
restore the blood-producing system. India is one of the most affordable global destinations for
bone marrow transplants.
Key Benefits:
● Potentially curative for leukaemia, lymphoma, and myeloma
● India has a growing national stem cell donor registry
● Haploidentical (half-matched family donor) transplants now available
● Cost is 80% lower than in the US or Europe
Success Rate
50–70% long-term survival in suitable ALL/AML patients undergoing allogeneic transplant
| Approx. Cost in India Rs. 15–25 lakh (vs Rs. 1.5–3 crore abroad) |
Liquid Biopsy & Precision Oncology
How It Works:
Liquid biopsy detects cancer DNA circulating in the blood (ctDNA) without a surgical biopsy. It
helps doctors identify mutations, monitor treatment response, and catch relapse early.
Combined with Next Generation Sequencing (NGS), it powers fully personalised cancer
treatment plans — often called Precision Oncology.
Key Benefits:
● No painful tissue biopsy required
● Detects cancer recurrence months before symptoms appear
● Identifies actionable mutations to guide targeted therapy
● Widely available at major diagnostic labs across India (Rs. 15,000–60,000)
Success Rate
Increases treatment response rates by 30–40% when used to guide targeted therapy
| Approx. Cost in India Rs. 15,000–60,000 for liquid biopsy + NGS panel |
PRRT (Peptide Receptor Radionuclide Therapy)
How It Works:
PRRT uses a radioactive molecule attached to a peptide that targets neuroendocrine tumour
(NET) cells specifically. Once attached, it delivers targeted radiation directly to the tumour.
Lutetium-177 DOTATATE (Lutathera) is the most common form, now available at select Indian
hospitals.
Key Benefits:
● Highly specific — targets only neuroendocrine tumour cells
● Effective for pancreatic NETs and carcinoid tumours
● Good quality of life maintained during treatment
● India offers PRRT at a fraction of the global cost
Success Rate
65–75% disease control rate; median PFS of 28+ months in mid-gut NETs
| Approx. Cost in India Rs. 2–4 lakh per cycle (4 cycles typically) |
Quick Comparison: Top 10 Treatments at a Glance
| Treatment | Best For | Success / Control Rate | India Cost (Approx) |
| Immunotherapy | All stages | 30–45% | Rs. 1.5–4L/cycle |
| CAR-T Cell Therapy | Blood cancers | 70–90% | Rs. 30–50L |
| Proton Therapy | Localised | 90%+ | Rs. 15–35L |
| Targeted Therapy | Mutation+ | 60–80% | Rs. 20K–2.5L/mo |
| Robotic Surgery | Solid tumours | 95%+ | Rs. 3–8L |
| CyberKnife / Gamma | Brain/Spine/Lung | 85–95% | Rs. 2.5–6L |
| HIPEC | Peritoneal | 4x longer | Rs. 5–10L |
| Stem Cell Transplant | Blood cancers | 50–70% | Rs. 15–25L |
| Liquid Biopsy + NGS | All types | +30–40% | Rs. 15–60K |
| PRRT | NETs | 65–75% | Rs. 2–4L/cycle |
Why Choose India for Advanced Cancer Treatment?
● Cost Savings: 60–80% cheaper than the US, UK, or Singapore for the same quality
treatment.x
● Expertise: India has 3,000+ oncologists trained at world-class institutions.
● Technology: Top hospitals have PET-CT, Proton Therapy, Robotic Surgery, and CAR-T all
under one roof.
● No Waiting: Unlike the UK NHS, private hospitals in India typically start treatment within 1–2
weeks.
● Accreditation: Hospitals like Apollo, Fortis, Manipal, and Max are JCI and NABH accredited.
● Medical Visa: India offers a dedicated medical e-visa for international patients — easy and
quick.
Final Takeaway
Cancer treatment in India has entered a new era in 2026. Whether you need
immunotherapy, proton therapy, CAR-T cell treatment, or robotic surgery — India’s top
hospitals offer world-class care at prices that are accessible to patients from all walks of
life. Always consult a qualified oncologist to determine the best treatment plan for your
specific cancer type and stage.






